148 related articles for article (PubMed ID: 21123980)
1. Efficacy of revascularization surgery for moyamoya syndrome associated with Graves' disease.
Endo H; Fujimura M; Niizuma K; Shimizu H; Tominaga T
Neurol Med Chir (Tokyo); 2010; 50(11):977-83. PubMed ID: 21123980
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review.
Nakamura H; Sato K; Yoshimura S; Hayashi Y; Izumo T; Tokunaga Y
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105414. PubMed ID: 33130479
[TBL] [Abstract][Full Text] [Related]
3. [Hyperperfusion after Revascularization for Quasi-moyamoya Disease Associated with Graves' Disease:A Case Report].
Shimonaga K; Mitsuhara T; Hosogai M; Kawasumi T
No Shinkei Geka; 2018 Jun; 46(6):501-508. PubMed ID: 29930211
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.
Ohba S; Nakagawa T; Murakami H
Neurosurg Rev; 2011 Jul; 34(3):297-304; discussion 304. PubMed ID: 21424208
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.
Fujimura M; Inoue T; Shimizu H; Saito A; Mugikura S; Tominaga T
Cerebrovasc Dis; 2012; 33(5):436-45. PubMed ID: 22456617
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions.
Narisawa A; Fujimura M; Tominaga T
Clin Neurol Neurosurg; 2009 Feb; 111(2):123-6. PubMed ID: 18995956
[TBL] [Abstract][Full Text] [Related]
7. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
[TBL] [Abstract][Full Text] [Related]
8. Moyamoya disease concurrent with Graves' disease treated by direct bypass: clinical features and treatment strategies.
Ryu B; Kawamata T; Yamaguchi K; Kawashima A; Ono M; Okada Y
Acta Neurochir (Wien); 2015 Jul; 157(7):1095-102. PubMed ID: 25929211
[TBL] [Abstract][Full Text] [Related]
9. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
Jea A; Smith ER; Robertson R; Scott RM
Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres.
Fujimura M; Tominaga T
Neurol Med Chir (Tokyo); 2012; 52(5):327-32. PubMed ID: 22688070
[TBL] [Abstract][Full Text] [Related]
11. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
Smith ER; McClain CD; Heeney M; Scott RM
Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
[TBL] [Abstract][Full Text] [Related]
12. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
[TBL] [Abstract][Full Text] [Related]
13. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
[TBL] [Abstract][Full Text] [Related]
14. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
Narisawa A; Fujimura M; Shimizu H; Tominaga T
No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
[TBL] [Abstract][Full Text] [Related]
15. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management.
Im SH; Oh CW; Kwon OK; Kim JE; Han DH
J Neurosurg; 2005 Jun; 102(6):1013-7. PubMed ID: 16028759
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya disease complicated by Graves' disease and type 2 diabetes mellitus: report of two cases.
Suzuki S; Mitsuyama T; Horiba A; Fukushima S; Hashimoto N; Kawamata T
Clin Neurol Neurosurg; 2011 May; 113(4):325-9. PubMed ID: 21215511
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya syndrome associated with Graves' disease: a case report and review of the literature.
Malik S; Russman AN; Katramados AM; Silver B; Mitsias PD
J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):528-36. PubMed ID: 21130668
[TBL] [Abstract][Full Text] [Related]
18. Familial moyamoya disease associated with Graves' disease in a mother and daughter. Two case reports.
Tokimura H; Tajitsu K; Takashima H; Hirayama T; Tsuchiya M; Takayama K; Arita K
Neurol Med Chir (Tokyo); 2010; 50(8):668-74. PubMed ID: 20805652
[TBL] [Abstract][Full Text] [Related]
19. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
